On March 29, 2010, the University of Utah and Myriad Genetics Inc. lost a U.S. court ruling over some of its patents for detecting inherited breast cancer related to the genes BRCA1 and BRCA2. The 152-page decision, which addresses questions about whether human genes should be subject to patent protection, could have major ramifications for […]
Research Tax Credits and Grants, Capped at $1 Billion, Boon for Small to Mid-sized Biotech Companies
Health care reform has produced a new tax credit and grant program for inventive small to mid-sized companies with R&D in therapeutics. Federal tax credits and grants will be awarded up to a national total of $1 billion for tax years 2009 and 2010 for winning, qualifying biotech projects. Companies with 250 or fewer employees […]
Issue 1 is a statewide ballot measure on the May 4 primary ballot that will renew and continue Ohio’s successful economic development and jobs creation program, the Ohio Third Frontier initiative. A public-private partnership created in 2002 with bipartisan leadership and support, Third Frontier makes targeted state investments in promising technologies, research and entrepreneurs – […]
The Becoming a Radiologist Technician blog has listed its 50 Best Blogs for Biotech Students list to keep biotechnologists well-informed about changes in the field. The list includes many friends we follow closely and some new (to us) blogs worth checking out. The list includes many favorites like these: 1. Biotech Blog by Yali Friedman. […]
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) is asking those in the biotech industry to support their work and connect you with others across the industry by joining the IAmBiotech community today. Every day, the men and women in the biotech industry work to solve our most daunting challenges. From the fight […]
Does Patent Reform Need Congressional Action? The Coalition for Patent Fairness (CPF) has put out a memo trying to debunk what it sees as the myth that patent reform no longer requires congressional action. From CPF: “The Court’s ability to effect needed changes is limited because it is restricted by the language Congress enacted more […]
The next quarterly meeting of the U.S. Patent and Trademark Office’s Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled: Wednesday, December 9, 2009 from 10:00 am to 5:00 pm Auditorium in Madison East, 600 Dulany Street, Alexandria, Virginia. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share […]
The NIH Office of Biotechnology Activities (OBA) tries to promote science, safety, and ethics in biotechnology through advancement of knowledge, enhancement of public understanding, and development of public policies. The OBA manages the Secretary’s Advisory Committee on Genetics, Health, and Society (SACGHS), which advises the Secretary of Health and Human Services on the broad range […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
